Flying The Web For News.
  • 2024 Presidential Election
    2024 Presidential Election
  • Career Exam Study
    Career Exam Study
  • E-commerce Guide
    E-commerce Guide
  • Dropshipping Guide
    Dropshipping Guide
  • Microsoft Exam
    Microsoft Exam
  • IT Career News
    IT Career News
+ Larger Font | - Smaller Font
Share

Globe NewsWire News Distribution Service

Press Release: Nurix Therapeutics Presents Positive Results from Ongoing Clinical Trial of NX-5948 in Patients with Relapsed Refractory Chronic Lymphocytic Leukemia (CLL) at the European Hematology Association Congress (EHA2024)

Details
Category: Globe NewsWire News Distribution Service

Objective response rate of 69.2% observed in heavily pretreated patient population including patients with BTK inhibitor resistance mutations Clinical responses in CLL patients were rapid and deepening with longer time on treatment


Posted: 2024-06-16 09:30:00

Get Full News Story On GlobeNewsWire Press Release Service



Listen to this article. Speaker link opens in a new window.
Text To Speech BETA Test Version.

Tags

press | release | nurix | therapeutics | presents


Related News Stories From The Web And More

Related Bing News Search Results

Press Release: Nurix Therapeutics Presents Positive Results from Ongoing Clinical Trial of NX-5948 in Patients with Relapsed Refractory Chronic Lymphocytic Leukemia (CLL) at the European Hematology Association Congress (EHA2024) - Newscast

Nurix Therapeutics Announces Presentations at the 7th Annual TPD & Induced Proximity Summit

Mon, 21 Oct 2024 13:08:00 GMT SAN FRANCISCO, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical stage biopharmaceutical company developing targeted protein modulation drugs designed to treat ...

Nurix Therapeutics Announces Presentations at the 7th Annual TPD & Induced Proximity Summit

Mon, 21 Oct 2024 09:00:00 GMT About Nurix Therapeutics, Inc. Nurix Therapeutics ... For additional information visit https://www.nurixtx.com. This press release contains forward-looking statements within the meaning of the ...

Nurix Therapeutics Expands Its Board of Directors with the Addition of Drug Commercialization Expert Anil Kapur

Wed, 16 Oct 2024 14:35:00 GMT SAN FRANCISCO, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Nurix Therapeutics ... Forward-Looking Statements This press release contains forward-looking statements within the meaning of the U.S. Private ...

Nurix Therapeutics Expands Its Board of Directors with the Addition of Drug Commercialization Expert Anil Kapur

Wed, 16 Oct 2024 13:35:00 GMT SAN FRANCISCO, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical stage biopharmaceutical company developing targeted protein modulation drugs designed to treat ...

Nurix Therapeutics adds pharma veteran Anil Kapur to board

Wed, 16 Oct 2024 09:40:00 GMT The information is based on a press release statement from Nurix Therapeutics, Inc. In other recent news, Nurix Therapeutics has seen significant attention from analysts due to its progress with ...


Blow Us A Whistle